About: http://data.cimple.eu/news-article/82a4b627f8fef3277a249140d9aa72d5c6341dfa4d435d36bd27db7e

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/82a4b627f8fef3277a249140d9aa72d5c6341dfa4d435d36bd27db7e Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	German group Curevac said Thursday it has signed a deal with Novartis for the Swiss pharmaceutical giant to help in its production of the Covid-19 vaccine it is developing. The Swiss giant will make up to 50 million doses of Curevac's vaccine by the end of 2021 and up to 200 million doses in 2022, said the German company. CureVac began the final Phase III trials of its vaccine candidate in mid-December, involving more then 35,000 volunteers in Europe and Latin America. hmn/fec/rl
schema:headline	Germany's Curevac says Swiss Novartis to help with Covid vaccine production
schema:mentions	Latin America Novartis Switzerland Europe Germany Coronavirus disease Vaccine Coronavirus disease 2019 CureVac
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	88 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software